Ardent Health Partners, LLC (NYSE:ARDT) Receives Average Rating of “Buy” from Brokerages

Ardent Health Partners, LLC (NYSE:ARDT) has been given an average recommendation of “Buy” by the twelve ratings firms that are currently covering the firm, MarketBeat.com reports. Two analysts have rated the stock with a hold recommendation, eight have given a buy recommendation and two have assigned a strong buy recommendation to the company. The average 12-month price target among analysts that have updated their coverage on the stock in the last year is $22.00.

ARDT has been the subject of a number of research reports. Bank of America downgraded shares of Ardent Health Partners from a “buy” rating to a “neutral” rating and reduced their price target for the company from $22.00 to $19.00 in a research report on Wednesday, November 6th. Stephens reaffirmed an “overweight” rating and set a $24.00 price objective on shares of Ardent Health Partners in a report on Thursday, September 19th. Royal Bank of Canada reissued an “outperform” rating and issued a $23.00 target price on shares of Ardent Health Partners in a report on Thursday, November 14th. Truist Financial cut their price target on Ardent Health Partners from $22.00 to $21.00 and set a “buy” rating for the company in a research note on Monday. Finally, Leerink Partners increased their price objective on shares of Ardent Health Partners from $23.00 to $25.00 and gave the company an “outperform” rating in a research note on Tuesday, November 12th.

Institutional Trading of Ardent Health Partners

A number of institutional investors and hedge funds have recently made changes to their positions in the company. BNP Paribas Financial Markets acquired a new position in Ardent Health Partners in the third quarter valued at $42,000. Financial Management Professionals Inc. acquired a new position in shares of Ardent Health Partners in the 3rd quarter valued at about $50,000. MetLife Investment Management LLC purchased a new stake in shares of Ardent Health Partners during the 3rd quarter worth about $135,000. JPMorgan Chase & Co. purchased a new stake in shares of Ardent Health Partners during the 3rd quarter worth about $154,000. Finally, Quadrature Capital Ltd acquired a new stake in Ardent Health Partners during the 3rd quarter worth approximately $229,000.

Ardent Health Partners Price Performance

Ardent Health Partners stock opened at $16.41 on Thursday. The company has a debt-to-equity ratio of 0.78, a current ratio of 1.91 and a quick ratio of 1.78. Ardent Health Partners has a one year low of $14.57 and a one year high of $20.72. The firm has a fifty day simple moving average of $16.66.

Ardent Health Partners Company Profile

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.